Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_assertion type Assertion NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_head.
- NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_assertion wasGeneratedBy ECO_0000203 NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_provenance.
- NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_assertion wasDerivedFrom befree-20150227 NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_provenance.
- NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_assertion SIO_000772 18068703 NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_provenance.
- NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_assertion evidence source_evidence_literature NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_provenance.
- NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_assertion description "[The frequencies of cancer-related gene methylation were as follows: 89% for RASSF1A, 52% for NEUROG1, 5% for DAP-kinase, RUNX3 and CACNA1G, and 0 for RAR-beta2, SOCS-1 and IGF-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800926.RAR-YXyAN6xPsYYgnkufGwconODdFwJ_nRAEmr3GmT6C4130_provenance.